These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 14510982)

  • 61. VML 295 (LY-293111), a novel LTB4 antagonist, is not effective in the prevention of relapse in psoriasis.
    Mommers JM; Van Rossum MM; Kooijmans-Otero ME; Parker GL; van de Kerkhof PC
    Br J Dermatol; 2000 Feb; 142(2):259-66. PubMed ID: 10730758
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Topical PTH (1-34) is a novel, safe and effective treatment for psoriasis: a randomized self-controlled trial and an open trial.
    Holick MF; Chimeh FN; Ray S
    Br J Dermatol; 2003 Aug; 149(2):370-6. PubMed ID: 12932245
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Hyperproliferation of normally quiescent keratinocytes in non-lesional psoriatic skin due to high calcium concentration (an organotypic culture model).
    Szabó AK; Bos JD; Das PK
    Acta Microbiol Immunol Hung; 2002; 49(1):129-40. PubMed ID: 12073819
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Bexarotene.
    Lowe MN; Plosker GL
    Am J Clin Dermatol; 2000; 1(4):245-50; discussion 251-2. PubMed ID: 11702369
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Suppression of proliferation of human epidermal keratinocytes by 1,25-dihydroxyvitamin D3. Analysis of its effect on psoriatic lesion and of its mechanism using human keratinocytes in culture.
    Kitano Y; Ikeda N; Okano M
    Eur J Clin Invest; 1991 Feb; 21(1):53-8. PubMed ID: 1907555
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of psoriasis activity and topical treatment on plasma epidermal growth factor (EGF) and its soluble receptor (sEGFR).
    Szterling-Jaworowska M; Baran A; Myśliwiec H; Flisiak I
    J Dermatolog Treat; 2018 Mar; 29(2):135-139. PubMed ID: 28621164
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II-III trial results.
    Duvic M; Hymes K; Heald P; Breneman D; Martin AG; Myskowski P; Crowley C; Yocum RC;
    J Clin Oncol; 2001 May; 19(9):2456-71. PubMed ID: 11331325
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Phenotypical and functional differences in germinative subpopulations derived from normal and psoriatic epidermis.
    Franssen ME; Zeeuwen PL; Vierwinden G; van de Kerkhof PC; Schalkwijk J; van Erp PE
    J Invest Dermatol; 2005 Feb; 124(2):373-83. PubMed ID: 15675957
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Monoclonal antibodies for epidermal population analysis.
    Bauer FW; Boezeman JB; van Engelen L; de Grood RM; Ramaekers FC
    J Invest Dermatol; 1986 Jul; 87(1):72-5. PubMed ID: 2425007
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A randomized, double-blind, vehicle-controlled, bilateral comparison trial of bexarotene gel 1% versus vehicle gel in combination with narrowband UVB phototherapy for moderate to severe psoriasis vulgaris.
    Magliocco MA; Pandya K; Dombrovskiy V; Christiansen L; Wong Y; Gottlieb AB
    J Am Acad Dermatol; 2006 Jan; 54(1):115-8. PubMed ID: 16384765
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Siramesine causes preferential apoptosis of mast cells in skin biopsies from psoriatic lesions.
    Hagforsen E; Lampinen M; Paivandy A; Weström S; Velin H; Öberg S; Pejler G; Rollman O
    Br J Dermatol; 2017 Jul; 177(1):179-187. PubMed ID: 28117878
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Response of the clinically uninvolved skin of psoriatic patients to tape stripping during acitretin treatment.
    Gerritsen MJ; van Pelt JP; van de Kerkhof PC
    Acta Derm Venereol; 1996 Jan; 76(1):6-9. PubMed ID: 8721480
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Methotrexate normalized keratinocyte activation cycle by overturning abnormal keratins as well as deregulated inflammatory mediators in psoriatic patients.
    Elango T; Thirupathi A; Subramanian S; Dayalan H; Gnanaraj P
    Clin Chim Acta; 2015 Dec; 451(Pt B):329-37. PubMed ID: 26499845
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Ultrasound imaging of psoriatic skin: a noninvasive technique to evaluate treatment of psoriasis.
    Vaillant L; Berson M; Machet L; Callens A; Pourcelot L; Lorette G
    Int J Dermatol; 1994 Nov; 33(11):786-90. PubMed ID: 7822083
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The response of distant uninvolved psoriatic skin to standardised injury is not different from that in normal skin.
    van Rossum MM; Mommers JM; van Hooijdonk CA; van Erp PE; van de Kerkhof PC
    Skin Pharmacol Appl Skin Physiol; 1999; 12(5):271-5. PubMed ID: 10461096
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Clinical clearing of psoriasis by 6-thioguanine correlates with cutaneous T-cell depletion via apoptosis: evidence for selective effects on activated T lymphocytes.
    Murphy FP; Coven TR; Burack LH; Gilleaudeau P; Cardinale I; Auerbach R; Krueger JG
    Arch Dermatol; 1999 Dec; 135(12):1495-502. PubMed ID: 10606055
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Regulation of involucrin in psoriatic epidermal keratinocytes: the roles of ERK1/2 and GSK-3β.
    Chen JQ; Man XY; Li W; Zhou J; Landeck L; Cai SQ; Zheng M
    Cell Biochem Biophys; 2013 Jul; 66(3):523-8. PubMed ID: 23283814
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Molecular mechanisms of tazarotene action in psoriasis.
    Duvic M; Nagpal S; Asano AT; Chandraratna RA
    J Am Acad Dermatol; 1997 Aug; 37(2 Pt 3):S18-24. PubMed ID: 9270552
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The epidermal phenotype during initiation of the psoriatic lesion in the symptomless margin of relapsing psoriasis.
    Castelijns FA; Gerritsen MJ; van Vlijmen-Willems IM; van Erp PE; van de Kerkhof PC
    J Am Acad Dermatol; 1999 Jun; 40(6 Pt 1):901-9. PubMed ID: 10365920
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Etanercept does not have an apoptosis-inducing effect on psoriatic keratinocytes.
    Tatlican S; Arikok A; Gulbahar O; Eren C; Cevirgen B; Eskioglu F
    J Dermatolog Treat; 2010 Sep; 21(5):306-10. PubMed ID: 19878038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.